An Open-Label, Single Arm Study of Obinutuzumab Short Duration Infusion in Patients With Previously Untreated Advanced Follicular Lymphoma
Clinical trial NCT03817853 · COMPLETED
Trial details
- NCT number
- NCT03817853
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-26
- Primary completion
- 2020-08-04
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.